BACKGROUND: Despite efforts to reduce antibiotic prescribing for acute respiratory infections (ARIs), information on factors that drive prescribing is limited. OBJECTIVE: To examine trends in antibiotic prescribing in the Veterans Affairs population over an 8-year period and to identify patient, provider, and setting sources of variation. DESIGN: Retrospective, cross-sectional study. SETTING: All emergency departments and primary and urgent care clinics in the Veterans Affairs health system. PARTICIPANTS: All patient visits between 2005 and 2012 with primary diagnoses of ARIs that typically had low proportions of bacterial infection. Patients with infections or comorbid conditions that indicated antibiotic use were excluded. MEASUREMENTS: Overall antibiotic prescription; macrolide prescription; and patient, provider, and setting characteristics extracted from the electronic health record. RESULTS: The proportion of 1 million visits with ARI diagnoses that resulted in antibiotic prescriptions increased from 67.5% in 2005 to 69.2% in 2012 (P < 0.001). The proportion of macrolide antibiotics prescribed increased from 36.8% to 47.0% (P < 0.001). Antibiotic prescribing was highest for sinusitis (adjusted proportion, 86%) and bronchitis (85%) and varied little according to fever, age, setting, or comorbid conditions. Substantial variation was identified in prescribing at the provider level: The 10% of providers who prescribed the most antibiotics did so during at least 95% of their ARI visits, and the 10% who prescribed the least did so during 40% or fewer of their ARI visits. LIMITATION: Some clinical data that may have influenced the prescribing decision were missing. CONCLUSION: Veterans with ARIs commonly receive antibiotics, regardless of patient, provider, or setting characteristics. Macrolide use has increased, and substantial variation was identified in antibiotic prescribing at the provider level. PRIMARY FUNDING SOURCE: U.S. Department of Veterans Affairs, Centers for Disease Control and Prevention.
BACKGROUND: Despite efforts to reduce antibiotic prescribing for acute respiratory infections (ARIs), information on factors that drive prescribing is limited. OBJECTIVE: To examine trends in antibiotic prescribing in the Veterans Affairs population over an 8-year period and to identify patient, provider, and setting sources of variation. DESIGN: Retrospective, cross-sectional study. SETTING: All emergency departments and primary and urgent care clinics in the Veterans Affairs health system. PARTICIPANTS: All patient visits between 2005 and 2012 with primary diagnoses of ARIs that typically had low proportions of bacterial infection. Patients with infections or comorbid conditions that indicated antibiotic use were excluded. MEASUREMENTS: Overall antibiotic prescription; macrolide prescription; and patient, provider, and setting characteristics extracted from the electronic health record. RESULTS: The proportion of 1 million visits with ARI diagnoses that resulted in antibiotic prescriptions increased from 67.5% in 2005 to 69.2% in 2012 (P < 0.001). The proportion of macrolide antibiotics prescribed increased from 36.8% to 47.0% (P < 0.001). Antibiotic prescribing was highest for sinusitis (adjusted proportion, 86%) and bronchitis (85%) and varied little according to fever, age, setting, or comorbid conditions. Substantial variation was identified in prescribing at the provider level: The 10% of providers who prescribed the most antibiotics did so during at least 95% of their ARI visits, and the 10% who prescribed the least did so during 40% or fewer of their ARI visits. LIMITATION: Some clinical data that may have influenced the prescribing decision were missing. CONCLUSION: Veterans with ARIs commonly receive antibiotics, regardless of patient, provider, or setting characteristics. Macrolide use has increased, and substantial variation was identified in antibiotic prescribing at the provider level. PRIMARY FUNDING SOURCE: U.S. Department of Veterans Affairs, Centers for Disease Control and Prevention.
Authors: Bob Z Sun; Alexander Chaitoff; Bo Hu; Kathleen Neuendorf; Mahesh Manne; Michael B Rothberg Journal: Br J Gen Pract Date: 2017-07-17 Impact factor: 5.386
Authors: Katherine E Fleming-Dutra; Monina Bartoces; Rebecca M Roberts; Lauri A Hicks Journal: Open Forum Infect Dis Date: 2018-01-05 Impact factor: 3.835
Authors: Yvonne C Lee; Bing Lu; Hongshu Guan; Jeffrey D Greenberg; Joel Kremer; Daniel H Solomon Journal: Arthritis Rheumatol Date: 2020-07 Impact factor: 10.995
Authors: Kevin L Schwartz; Bradley J Langford; Nick Daneman; Branson Chen; Kevin A Brown; Warren McIsaac; Karen Tu; Elisa Candido; Jennie Johnstone; Valerie Leung; Jeremiah Hwee; Michael Silverman; Julie H C Wu; Gary Garber Journal: CMAJ Open Date: 2020-05-07
Authors: Aditi Patel; Elizabeth R Pfoh; Anita D Misra Hebert; Alexander Chaitoff; Aryeh Shapiro; Niyati Gupta; Michael B Rothberg Journal: J Gen Intern Med Date: 2019-10-19 Impact factor: 5.128
Authors: Michael B Steinberg; Ayse Akincigil; Eun Jung Kim; Rory Shallis; Cristine D Delnevo Journal: Am J Prev Med Date: 2015-12-15 Impact factor: 5.043
Authors: Michael S Pulia; Sara C Keller; Christopher J Crnich; Robin L P Jump; Thomas T Yoshikawa Journal: J Am Geriatr Soc Date: 2019-11-21 Impact factor: 5.562
Authors: Kevin L Schwartz; Camille Achonu; Kevin Antoine Brown; Bradley Langford; Nick Daneman; Jennie Johnstone; Gary Garber Journal: CMAJ Open Date: 2018-10-31